MoneyWorks4Me

Mangalam Drugs and Organics gets CEP for Hydroxychloroquine Sulphate

20 May 2020 Evaluate

Mangalam Drugs and Organics has received Certificate of Suitability (CEP) for API - Hydroxychloroquine Sulphate (HCQS) from European Directorate for the Quality of Medicines & Healthcare (EDOM).

Mangalam Drugs and Organics manufactures chemicals such as API perfumery, disperse dye intermediates, bulk drugs and bulk drugs intermediates at VAPI-Gujarat State. It has a multi-product manufacturing facility and a in-house Research and Development (R&D) Base.

Mangalam Drugs&Org. Share Price

28.07 0.12 (0.43%)
18-Aug-2026 14:30 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1875.65
Dr. Reddys Labs. 1187.20
Cipla 1432.60
Lupin 2223.65
Zydus Lifesciences 1121.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: